{
  "id": "cluster_15_doc3",
  "content": "Effective immediately, Sunrise Health Network requires prior authorization for all sublingual immunotherapy claims exceeding 12-month duration. New claim code bundles (TX815-TX817) must accompany supporting medical necessity documentation. Exception process available for clinical trial participants through the Mountain View research office, subject to IRB verification. Policy impacts approximately 18% of pediatric allergy cases network-wide.",
  "metadata": {
    "format": "policy_document"
  }
}